December 19, 2011 — In its new report, Emerging Markets For Microfluidic Applications, Yole Développement asserts that microfluidics are a "key technology" for the life sciences market, which will prop up microfluidics growth to $4 billion in 2016. The report provides analysis of microfluidic device markets and technologies with market data for 2008-2010 and forecasts for 2010-2016.
The microfluidic device market is quickly evolving and entering a "structuration and consolidation phase," said report author Frédéric Breussin, Yole Développement. Many products are moving from prototyping to production. Many new players recently entered the supply chain, bringing expertise in the mass production of electronic devices and modules. This could create a microfluidics eco system where production costs are reduced enough to make disposable microfluidic devices accessible for the medical market.
Also read: Microfluidics foundry opens under A*STAR in Singapore
The boundaries between microfluidics applications in the life sciences field are often blurred, says Breussin. These include general dispensing, drug delivery, accurate dispensing, analytics, clinical and veterinary diagnostics, point-of-care testing, industrial and environmental testing, pharmaceutical and life science use, and microreaction technology.
| Figure. Microfluidics supply and value chain. SOURCE: Yole, September 2011. |
 |
Yole Développement’s report describes the microfluidic supply chain, from R&D to commercialization and distribution. It shows for main players and their role in the supply chain for each type of material, and the costs related to manufacturing steps, as well as final product costs.
Companies cited in the report:
AB SCIEX, Abaxis, Abbott, Advion Biosciences, AES Laboratoire , Agilent Technologies, Bartels mikrotechnik, BD, Bertin Technologies, Biodiot, BioFluidix, bioMérieux, Biosite, Boehringer Ingelheim, Bürkert, Caliper Life Sciences, Cellectricon, Cepheid, Cetoni , Cytoo, Dalsa, Danaher, Debiotech, Dolomite, Eksigent Technologies, Epocal, Fluidigm, Fluigent, GE Novasensor, Genewave, GeSim, Great Basin, Hamilton, Ikerlan, Illumina, IMM, Invitrogen, Johnson & Johnson, Konica Minolta Opto, LabCyte, Life Technologies, Merlin diagnostic, MicroCHIPS, Micronit, MicroParts, Nanostream, Ocusense, Pall Genesystem, PerkinElmer, Philips, PositiveID Corporation, Qiagen, Raindance Technologies, Roche Applied Science, Samsung, Scienion, Sensirion, Seyonic, Shimadzu Biotech, Shrink Nanotechnologies, Siemens Medical Solutions, Sony DADC, Sophion, Stmicroelectronics, Texas Instrument, Tokyo Electron, Vantix Ltd, etc.
Frédéric Breussin is an expert in microfluidics for diagnostics and life sciences.
Benjamin Roussel is a market analyst in microfluidics and medical technologies.
Contact David Jourdan for report information: [email protected] or +33 472 83 01 90, or visit www.yole.fr.